MedTrace Logo

Intravenous Paracetamol or Morphine for the Treatment of Acute Flank Pain

NCT01318187 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2011-04-01

No results posted yet for this study

Summary

STUDY OBJECTIVE: This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol and morphine for the treatment of acute flank pain.

METHODS: The investigators conducted a randomized, double-blind, controlled clinical trial comparing single intravenous doses of paracetamol (1 g) and morphine (0.1 mg/kg) for patients presenting to the emergency department (ED) with acute flank pain. Subjects with inadequate pain relief at 30 minutes received rescue fentanyl (0.75 microg/kg).

Conditions

  • Urolithiasis

Interventions

DRUG

paracetamol

1 gr

DRUG

morphine

0.1mg/kg intravenous in 100 ml serum physiologic

DRUG

Paracetamol

1 gr intravenous

DRUG

Paracetamol

intravenous 1 gr

DRUG

Morphine

0.1 mg/kg intravenous

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Principal Investigators

  • Mustafa Serinken, Proffesor · Pamukkale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318187 on ClinicalTrials.gov